M

McKesson Europe AG
XHAM:CLS1

Watchlist Manager
McKesson Europe AG
XHAM:CLS1
Watchlist
Price: 24.4 EUR Market Closed
Market Cap: 5B EUR
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

CLS1 latest financial reports are more than 5 years old.

There is not enough data to reliably calculate the relative value of CLS1.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CLS1 Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

0.2
P/S
P/S
Price to Sales
0.2
vs History
vs Industry
Median 3Y
0.2
Median 5Y
0.2
Industry
2.2
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-5.1
Median 5Y
-5.1
Industry
21.9
More Details
11.7
P/OCF
P/OCF
Price to OCF
11.7
vs History
vs Industry
Median 3Y
11.7
Median 5Y
11.7
Industry
13.5
More Details
30.1
P/FCFE
P/FCFE
Price to FCFE
30.1
vs History
vs Industry
Median 3Y
30.1
Median 5Y
30.1
Industry
19.2
More Details
2.6
P/B
P/B
Price to Book Value
2.6
vs History
vs Industry
Median 3Y
2.7
Median 5Y
2.7
Industry
2.1
More Details
0.3
EV/S
EV/S
Enterprise Value to Sales
0.3
vs History
vs Industry
Median 3Y
0.3
Median 5Y
0.3
Industry
2.3
More Details
2.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.5
vs History
vs Industry
Median 3Y
2.5
Median 5Y
2.5
Industry
4.8
More Details
3.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
3.9
vs History
vs Industry
Median 3Y
3.9
Median 5Y
3.9
Industry
11.7
More Details
19.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
19.2
vs History
vs Industry
Median 3Y
19.2
Median 5Y
19.2
Industry
15.9
More Details
12.5
EV/OCF
EV/OCF
Enterprise Value to OCF
12.5
vs History
vs Industry
Median 3Y
12.5
Median 5Y
12.5
Industry
13.3
More Details
19.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
19.8
vs History
vs Industry
Median 3Y
19.8
Median 5Y
19.8
Industry
16.8
More Details
1.4
EV/IC
EV/IC
Enterprise Value to IC
1.4
vs History
vs Industry
Median 3Y
1.4
Median 5Y
1.4
Industry
1.8
More Details

Multiples Across Competitors

CLS1 Competitors Multiples
McKesson Europe AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
McKesson Europe AG
XHAM:CLS1
5B EUR 0.2 -5.1 3.9 19.2
US
Mckesson Corp
NYSE:MCK
86.1B USD 0.2 30.5 18.1 20.7
US
Cencora Inc
NYSE:COR
54B USD 0.2 38.7 13.5 18.5
US
Amerisourcebergen Corp
LSE:0HF3
54.1B USD 0.2 38.8 13.6 18.6
US
Cardinal Health Inc
NYSE:CAH
31.4B USD 0.1 23.9 11.5 15.3
AU
Sigma Healthcare Ltd
ASX:SIG
33.4B AUD 9.4 -11 105.6 4 335.8 4 335.8
CN
Huadong Medicine Co Ltd
SZSE:000963
68B CNY 1.6 21.2 16.5 16.5
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW 5.9 89.6 59.9 61.9
AU
EBOS Group Ltd
OTC:EBOSY
8.2B USD 1.1 55.4 32.8 32.8
US
Henry Schein Inc
NASDAQ:HSIC
8.1B USD 0.6 20.8 10.1 14.2
CN
Sinopharm Group Co Ltd
HKEX:1099
52.6B HKD 0.1 7.2 0.4 0.4
P/E Multiple
Earnings Growth PEG
DE
M
McKesson Europe AG
XHAM:CLS1
Average P/E: 36.2
Negative Multiple: -5.1 		N/A N/A
US
Mckesson Corp
NYSE:MCK
30.5
21%
1.5
US
Cencora Inc
NYSE:COR
38.7
34%
1.1
US
A
Amerisourcebergen Corp
LSE:0HF3
38.8
34%
1.1
US
Cardinal Health Inc
NYSE:CAH
23.9
42%
0.6
AU
Sigma Healthcare Ltd
ASX:SIG
Negative Multiple: -11 105.6
457%
N/A
CN
Huadong Medicine Co Ltd
SZSE:000963
21.2
16%
1.3
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
89.6
42%
2.1
AU
E
EBOS Group Ltd
OTC:EBOSY
55.4
9%
6.2
US
Henry Schein Inc
NASDAQ:HSIC
20.8
24%
0.9
CN
Sinopharm Group Co Ltd
HKEX:1099
7.2
5%
1.4

See Also

Summary
CLS1 intrinsic value, competitors valuation, and company profile.
DCF Valuation
CLS1 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CLS1 stock valuation using valuation multiples.
Wall Street Estimates
CLS1 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CLS1 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 244,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.